Exam (elaborations)
Acute Coronary Syndrome (Carl Shapiro) Exam Questions and Answers
Institution
Carl Shapiro Vsim
Acute Coronary Syndrome (Carl Shapiro) Exam Questions and Answers
[Show more]
Uploaded on
October 20, 2024
Number of pages
9
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
Institution
Carl Shapiro vsim
Module
Carl Shapiro vsim
£9.73
Also available in package deal from £25.37
Added
Add to cart
Add to wishlist
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (1)
Vsim carl shapiro Exam Bundle
1. Exam (elaborations) - Acute coronary syndrome (carl shapiro) exam questions and answers
2. Exam (elaborations) - Carl shapiro (coronary artery disease) exam and answers
3. Exam (elaborations) - Carl shapiro coronary artery disease exam questions and answers
4. Exam (elaborations) - Carl shapiro vsim post quiz with correct answers
5. Exam (elaborations) - Moc carl shapiro exam questions and answers (graded a)
6. Exam (elaborations) - Vsim - cardiac (shapiro and cooper) exam questions and answers
7. Exam (elaborations) - Vsim 2 carl shapiro mi exam questions and answers
8. Exam (elaborations) - Vsim medical scenario 4 carl shapiro exam questions and answers
Show more
Acute Coronary Syndrome (Carl
Shapiro) Exam Questions and Answers
When iia iipatient iiis iiexperiencing iiangina, iithe iinurse iiadministers iinitroglycerin
iisublingually iiat iiwhat iifrequency?
A. iievery ii15 iiminutes, ii3 iidoses iimax
B. iiEvery ii3 iimin, iino iirestriction iion ii# iiof iidoses
C. iiEvery ii5 iimin, ii3 iidose iimax
D. iiOnce iionly, iithen iiadminister iimorphine ii- iiAnswers ii-C. iievery ii5 iimin, ii3 iidose iimax
when iia iipatient iiis iiexperiencing iiacute iiangina, iiit iiis iirecommended iithat iithe iipatient
iiallow iione iisublingual iitablet iito iidissolve iiunder iithe iitongue ii(or iispray iinitroglycerin
iiunder iithe iitongue) iiand iirepeat iievery ii5 iiminutes iifor iia iimax iiof ii3 iidoses.
When iiadministering iimedication iito iithe iipatient iiwith iisuspected iimyocardial iiinfarction,
iithe iinurse iiunderstands iithat iimorphine iihas iiwhich iiof iithe iifollowing iibeneficial iieffects?
ii(SATA)
A. iidecreases iipreload
B. iidecreases iirespiratory iirate
C. iidecreases iipain
D. iidecreases iiafter-load
E. iidecreases iianxiety ii- iiAnswers ii-A, iiC, iiD, iiE
morphine iiis iithe iidrug iiof iichoice iito iireduce iipain, iithereby iireducing iianxiety. iiIt iialso
iireduces iipreload iiand iiafterload, iidecreasing iithe iiwork iiof iithe iiheart. ii
****The iipatient iimust iibe iimonitored iiclosely iifor iithe iiside iieffects iiof iihypotension iiand
iirespiratory iidepression.
Which iiof iithe iifollowing iiare iicardiac iimarkers iiassessed iiin iithe iipatient iiexperiencing
iiangina iito iidetermine iipotential iimyocardial iiinjury? ii(SATA)
A. iiCK-MB
B. iiHemoglobin
C. iiCK-MM
D. iiCreatinine
E. iiTroponin ii- iiAnswers ii-A, iiE ii
Cardiac iienzymes iiand iibiomarkers, iiwhich iiinclude iitroponn, iicreatine iikinase ii(CK) iiand
iimyoglobin iiare iiused iito iidiagnose iian iiacute iiMI. iiOf iithe ii3 iiCK iiisoenzymes, iiCK
iimyocardial iibound ii(MB) iiis iispecific iito iithe iiheart iimuscle.
The iinurse iirecognizes iithat iiST iielevation iion iithe ii12 iilead iiECG iitypically iiindicates
iiwhich iiof iithe iifollowing?
A. iimyocardial iiinjury
, B. iimyocardial iiischemia
C. iithis iiis iia iinormal iifinding
D. iihyperkalemia ii- iiAnswers ii-A. iimyocardial iiinjury
myocardial iiinjury iicauses iiST-segment iiand iiT-wave iichanges iion iian iiECG
The iinurse iiknows iithat iiwhich iifactors iimay iiincrease iithe iipatient's iirisk iiof iideveloping
iicoronary iiartery iidisease? ii(SATA)
A. iicigarette iismoking
B. iimetabolic iisyndrome
C. iiactivity iilimited iito iiwalking
D. iifemale iiless iithan iiage ii55
E. iifamily iihistory ii- iiAnswers ii-A, iiB, iiE
Non-modifiable iirisk iifactors iifor iiCAD iiinclude iifamily iihistory iiand iiincreasing iiage
ii(more iithan ii55 iiyrs. iifor iiwomen). iiCigarette iismoking iiand iimetabolic iisyndrome iiare
iimodifiable iirisk iifactors iifor iiCAD. iiA iidiagnosis iiof iimetabolic iisyndrome iiincludes ii3 iiof
iithe iifollowing iiconditions:
*Insulin iiresistance
*Central iiobesity
*Dyslipidemia
*BP iiconsistently ii>130/85
*High iilevels iiof iiC-reactive iiprotein
*High iifibrinogen iilevels
Which iiof iithe iifollowing iidoes iithe iinurse iirecognize iias iitypical iisigns iiand iisymptoms
iiexhibited iiby iia iipatient iiexperiencing iiangina? ii(SATA)
A. iidiaphoresis
B. iitenderness iiover iiapical iiarea
C. iiShortness iiof iibreath
D. iiPain iion iiinspiration
E. iiSubsternal iichest iipain ii- iiAnswers ii-A, iiC, iiE: iidiaphoresis, iiSOB, iichest iipain
Typical iis&s iiof iiangina iican iiinclude iichest iipain iior iiheaviness iithat iimay iiradiate, iiSOB,
iidusky iior iipallor iiskin, iidiaphoresis, iiweakness, iiN&V, iiand iidenial iiby iithe iipatient.
The iinurse iiunderstands iithat iiaspirin iiis iiadministered iito iia iipatient iiwith iia iisuspected
iimyocardial iiinfarction ii(MI) iifor iiwhich iiof iithe iifollowing iireasons
A. iito iipromote iithrombolysis
B. iito iiimprove iioxygenation iito iithe iimyocardium
C. iito iiprevent iiventricular iidysrhythmias
D. iito iiprevent iiplatelet iiaggregation ii- iiAnswers ii-D. iito iiprevent iiplatelet iiaggregation
the iipatient iiwith iia iisuspected iiMI iishould iireceive iiaspirin iiimmediately, iiunless iiallergic
iito iiit, iito iihelp iiplatelet iiaggregation